Pathophysiology of Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation and systemic manifestations. The pathogenesis of RA involves a complex interplay of genetic predispositions and environmental factors that contribute to autoantibody production and breakdown of immune self-tolerance. This review elaborates on the significant role of autoantibodies such as anticitrullinated protein antibodies (ACPAs), and genetic factors including HLA-DRB1 gene variants, in the initiation of the disease process. It further explores how environmental exposures like smoking and bacterial infections enhance susceptibility to RA. The article highlights the dysregulation of cytokine networks, emphasizing both proinflammatory cytokines such as TNF-α, IL-1, and IL-6, which drive the inflammatory processes, and anti-inflammatory cytokines like IL- 10 and IL-35, which attempt to modulate these responses. The pathology of RA is marked by the proliferation of fibroblast-like synoviocytes (FLS), excessive cytokine release, and the subsequent joint destruction. Insights into the molecular pathways of cytokine interaction and genetic markers provide a deeper understanding of RA mechanisms and underscore the importance of targeted therapeutic strategies. This comprehensive review underscores the need for continued research to refine our understanding of RA and improve management strategies, with a particular focus on cytokine targeting and modification of environmental risk factors such as smoking cessation.